Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06088771
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-10-06
Brief Title:
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Sponsor:
Organization:
Icahn School of Medicine at Mount Sinai